Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Market Cap	12.50B
Revenue (ttm)	1.20B
Net Income (ttm)	113.60M
Shares Out	n/a
EPS (ttm)	0.19
PE Ratio	110.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	25.91
Previous Close	25.91
Day's Range	25.91 - 25.91
52-Week Range	14.00 - 25.91
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 21, 2024

About FSPKF

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,031
• Stock Exchange: OTCMKTS
• Ticker Symbol: FSPKF

Financial Performance

In 2023, FSPKF's revenue was 1.74 billion, an increase of 10.23% compared to the previous year's 1.58 billion. Earnings were 132.60 million, a decrease of -47.02%.

Financial numbers in NZD